CM

Cheryl Maley

Starpharma Holdings Limited | Chief Executive Officer, Managing Director
Ms Maley has over 25 years of experience in the pharmaceutical industry, including 20 years in leadership roles at well known and leading organisations, including Novartis and AbbVie. Her previous roles include nine years at Novartis in senior commercial and executive roles and various sales and marketing positions with AbbVie/Abbott, Servier Laboratories, and Wyeth Pharmaceuticals. She has experience leading pharmaceutical innovation, marketing strategies, and business growth across Australia, Asia, and international markets. During her nine year career at Novartis, she held senior leadership positions, responsible for new products, commercialisation, strategy, and reimbursement matters. She also held General Management roles in both the Philippines and Australia. Prior to joining Starpharma, she was Acting CEO and Strategic Advisor at Biointelect, a firm specialising in strategic planning and commercialisation for the biopharmaceutical and medical device sector. She holds a board position at Neuroscience Research Australia.

Company and Roles

Company
Title
Tenure
Since
SPL
Starpharma Holdings Limited
  • Chief Executive Officer
  • Managing Director
2yrs, 6mthJan 2024

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
SPL
Starpharma Holdings Limited
26/08/25125,000N/AN/AN/A
01/02/230N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
SPL
Starpharma Holdings Limited
12/12/25
Issued
6,525,939$0.365$2,381,967Issue of securities
SPL
Starpharma Holdings Limited
30/09/25
Expiry
439,752$0.255$112,136As advised by the company
SPL
Starpharma Holdings Limited
11/12/24
Issued
5,202,703$0.115$598,310Issue of securities
SPL
Starpharma Holdings Limited
30/05/24
Buy
125,000$0.113$14,065On-market trade